What is a Cipla MTP Kit Oklahoma
Cipla MTP kit in Oklahoma is a combination package of 1 tablet of mifepristone and 4 tablets of misoprostol. It is indicated for the drug termination of intrauterine pregnancy up to 63 days of pregnancy based on the first day of the last menstrual period.
Mifepristone (RU 486) is a synthetic steroid with anti-progestational activity due to competition with progesterone at the progesterone receptors. While misoprostol is a synthetic prostaglandin E1. At recommended doses, misoprostol induces contraction of smooth muscle in the myometrium and relaxation of the cervix. The uterotonic properties of misoprostol should facilitate the opening of the cervix and the evacuation of the conception product.
The dosage is mifepristone 200 mg orally, followed 1-3 days later by misoprostol 800 mcg (4 tablets of 200 mcg) vaginally. The patient should return for a follow-up visit approximately 14 days after mifepristone administration.
The product may only be used under the supervision of a service provider and in a medical facility as specified in MTP Act 2002 and MTP Rules 2003
Benefits of Cipla MTP kit in Oklahoma
Side Effects of Cipla MTP kit in Oklahoma
Common side effects of MTP Kit
- Stomach cramp
- Uterine contractions
- Menorrhagia (heavy menstrual bleeding)